FatPipe, Inc.

FATN · NasdaqCM · Stock · Technology
$5.00
+0.20% today
Delayed price,

What FatPipe does

FatPipe, Inc. develops application-aware, secure software-defined wide area network, secure access service edge, and network monitoring service (NMS) software solutions in the United States, India, and internationally. The company offers SD-WAN, a network architecture solution that allows enterprises to utilize software and virtualization technologies to enhance the performance, security, and manageability of their WANs that connect offices, data centers, cloud applications, and cloud storage; SASE that provides virtual network functions, which combine networking and network security services into a single cloud-delivered solution; and NMS, a EnterpriseView reporting system for network monitoring that provides a platform to monitor an end-user's WAN and the performance of FatPipe devices under management. It also provides technical support services, professional, technology development, cyber security, and training services. In addition, the company offers its solutions to enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. The company sells its software solutions through a subscription-based model through a network of distributors, value-added resellers, internet service providers, and other third parties. FatPipe, Inc. was incorporated in 2009 and is headquartered in Salt Lake City, Utah.

Key facts

Sector
Technology
Industry
Software - Infrastructure
Market cap
$70.6M
P/E (ttm)
12.8
Forward P/E
9.7
Dividend yield
0.00%
Beta
—
Profit margin
26.8%
Employees
172
Headquarters
Salt Lake City, UT, United States
Exchange
NasdaqCM

Performance

1 Month
-12.7%
3 Months
+10.1%
6 Months
+129.4%
1 Year
+14.4%
5 Years
-44.1%
$1.3152-week range$8.61
Biggest setback — last 12 months
-67.5%
20 Oct 2025 → 23 Feb 2026
Fell from $4.49 to $1.46 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+445.2%
23 Feb 2026 → 25 May 2026
Ran from $1.46 to $7.96 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$3.68 (-26.3%)$5.00$6.79 (+35.7%)
3 Months$2.95 (-41.1%)$5.00$8.49 (+69.7%)
6 Months$2.37 (-52.7%)$5.00$10.57 (+111.3%)
12 Months$1.74 (-65.3%)$5.00$14.40 (+188.1%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 105.8%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 1,000 shares — Turgeon Jean Pierre, Director · 2026-07-13
Acquired 1,000 shares — Tandon Ajay Hari, Director · 2026-07-13
Acquired 1,000 shares — Majumder I. Bobby, Director · 2026-06-18
Acquired 20,000 shares at $1.45 — Bhaskar Ragula, Director · 2026-03-25
Acquired 4,500 shares at $2.15 — Datta Sanchaita, Director · 2026-01-28
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.